These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A selective cyclic integrin antagonist blocks the integrin receptors alphavbeta3 and alphavbeta5 and inhibits retinal pigment epithelium cell attachment, migration and invasion. Hoffmann S; He S; Jin M; Ehren M; Wiedemann P; Ryan SJ; Hinton DR BMC Ophthalmol; 2005 Jun; 5():16. PubMed ID: 15987521 [TBL] [Abstract][Full Text] [Related]
4. IL-10 and antibodies to TGF-beta2 and PDGF inhibit RPE-mediated retinal contraction. Carrington L; McLeod D; Boulton M Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1210-6. PubMed ID: 10752962 [TBL] [Abstract][Full Text] [Related]
8. Implication of protein carboxymethylation in retinal pigment epithelial cell chemotaxis. Hackett SF; Campochiaro PA Ophthalmic Res; 1988; 20(1):54-9. PubMed ID: 3380525 [TBL] [Abstract][Full Text] [Related]
9. Mitogen-activated protein kinase activation mediates PDGF-directed migration of RPE cells. Hinton DR; He S; Graf K; Yang D; Hsueh WA; Ryan SJ; Law RE Exp Cell Res; 1998 Feb; 239(1):11-5. PubMed ID: 9511719 [TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of proliferative vitreoretinopathy. Modulation of retinal pigment epithelial cell functions by vitreous and macrophages. Kirchhof B; Sorgente N Dev Ophthalmol; 1989; 16():1-53. PubMed ID: 2676632 [TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Robbins SG; Mixon RN; Wilson DJ; Hart CE; Robertson JE; Westra I; Planck SR; Rosenbaum JT Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3649-63. PubMed ID: 8088954 [TBL] [Abstract][Full Text] [Related]
12. Additive effects of extra cellular matrix proteins and platelet derived mitogens on human retinal pigment epithelial cell proliferation and contraction. Smith-Thomas L; Richardson P; Parsons MA; Rennie IG; Benson M; MacNeil S Curr Eye Res; 1996 Jul; 15(7):739-48. PubMed ID: 8670782 [TBL] [Abstract][Full Text] [Related]
13. [The effect of platelet-derived growth factor on the formation of proliferative vitreoretinopathy]. Liang Y; Li X; Fan J; Zhao M; Jiang Y Zhonghua Yan Ke Za Zhi; 2002 Mar; 38(3):144-7. PubMed ID: 11955317 [TBL] [Abstract][Full Text] [Related]
15. Vitreous modulation of migration and proliferation of retinal pigment epithelial cells in vitro. Kirchhof B; Kirchhof E; Ryan SJ; Sorgente N Invest Ophthalmol Vis Sci; 1989 Sep; 30(9):1951-7. PubMed ID: 2777515 [TBL] [Abstract][Full Text] [Related]
16. Platelet-derived growth factor is an autocrine growth stimulator in retinal pigmented epithelial cells. Campochiaro PA; Hackett SF; Vinores SA; Freund J; Csaky C; LaRochelle W; Henderer J; Johnson M; Rodriguez IR; Friedman Z J Cell Sci; 1994 Sep; 107 ( Pt 9)():2459-69. PubMed ID: 7844163 [TBL] [Abstract][Full Text] [Related]
17. A potential role for PDGF-C in experimental and clinical proliferative vitreoretinopathy. Lei H; Hovland P; Velez G; Haran A; Gilbertson D; Hirose T; Kazlauskas A Invest Ophthalmol Vis Sci; 2007 May; 48(5):2335-42. PubMed ID: 17460299 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of dedifferentiation and myoid differentiation of retinal pigment epithelial cells by platelet derived growth factor. Ando A; Ueda M; Uyama M; Masu Y; Ito S Br J Ophthalmol; 2000 Nov; 84(11):1306-11. PubMed ID: 11049960 [TBL] [Abstract][Full Text] [Related]
19. PDGF-C and -D induced proliferation/migration of human RPE is abolished by inflammatory cytokines. Li R; Maminishkis A; Wang FE; Miller SS Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5722-32. PubMed ID: 18055825 [TBL] [Abstract][Full Text] [Related]
20. Proliferative vitreoretinopathy. The mechanism of development of vitreoretinal traction. Glaser BM; Cardin A; Biscoe B Ophthalmology; 1987 Apr; 94(4):327-32. PubMed ID: 3587912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]